ADRIAMYCIN PFS Comprehensive clinical and safety monograph for ADRIAMYCIN PFS (ADRIAMYCIN PFS). | Anthracycline Antineoplastic | caution |
AFATINIB Comprehensive clinical and safety monograph for AFATINIB (AFATINIB). | Tyrosine Kinase Inhibitor Antineoplastic | caution |
AFINITOR Comprehensive clinical and safety monograph for AFINITOR (AFINITOR). | mTOR Inhibitor Antineoplastic | caution |
AFINITOR DISPERZ Comprehensive clinical and safety monograph for AFINITOR DISPERZ (AFINITOR DISPERZ). | mTOR Inhibitor Antineoplastic | caution |
AGRYLIN Comprehensive clinical and safety monograph for AGRYLIN (AGRYLIN). | Antineoplastic Agent | caution |
AKEEGA Comprehensive clinical and safety monograph for AKEEGA (AKEEGA). | Antineoplastic Combination | caution |
ALECENSA Comprehensive clinical and safety monograph for ALECENSA (ALECENSA). | Kinase Inhibitor Antineoplastic | caution |
ALIMTA Comprehensive clinical and safety monograph for ALIMTA (ALIMTA). | Antifolate Antineoplastic | caution |
ALIQOPA Comprehensive clinical and safety monograph for ALIQOPA (ALIQOPA). | PI3K Inhibitor Antineoplastic | caution |
ALKERAN Comprehensive clinical and safety monograph for ALKERAN (ALKERAN). | Alkylating Agent Antineoplastic | caution |
ANZUPGO Comprehensive clinical and safety monograph for ANZUPGO (ANZUPGO). | Antineoplastic | caution |
ARRANON Comprehensive clinical and safety monograph for ARRANON (ARRANON). | Antineoplastic | caution |
ARSENIC TRIOXIDE Comprehensive clinical and safety monograph for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE). | Antineoplastic | caution |
ARZERRA Comprehensive clinical and safety monograph for ARZERRA (ARZERRA). | Antineoplastic, Monoclonal Antibody | caution |
ASPARLAS Comprehensive clinical and safety monograph for ASPARLAS (ASPARLAS). | Antineoplastic, Enzyme | caution |
AURLUMYN Comprehensive clinical and safety monograph for AURLUMYN (AURLUMYN). | Antineoplastic Agent | caution |
AVASTIN Comprehensive clinical and safety monograph for AVASTIN (AVASTIN). | Antineoplastic (Angiogenesis Inhibitor) | caution |
AVGEMSI Comprehensive clinical and safety monograph for AVGEMSI (AVGEMSI). | Antineoplastic (Nucleoside Analog) | caution |
AVOPEF Comprehensive clinical and safety monograph for AVOPEF (AVOPEF). | Antineoplastic | caution |
BAVENCIO Comprehensive clinical and safety monograph for BAVENCIO (BAVENCIO). | Antineoplastic (PD-L1 Inhibitor) | caution |
BEIZRAY Comprehensive clinical and safety monograph for BEIZRAY (BEIZRAY). | Antineoplastic (HIF-2α Inhibitor) | caution |
BEXAROTENE Comprehensive clinical and safety monograph for BEXAROTENE (BEXAROTENE). | Retinoid Antineoplastic | caution |
BICALUTAMIDE Comprehensive clinical and safety monograph for BICALUTAMIDE (BICALUTAMIDE). | Antiandrogen Antineoplastic | caution |
BICNU Comprehensive clinical and safety monograph for BICNU (BICNU). | Alkylating Agent Antineoplastic | caution |
BLENOXANE Comprehensive clinical and safety monograph for BLENOXANE (BLENOXANE). | Antineoplastic Antibiotic | caution |
BLENREP Comprehensive clinical and safety monograph for BLENREP (BLENREP). | Antineoplastic, Monoclonal Antibody | caution |
BLEOMYCIN SULFATE Comprehensive clinical and safety monograph for BLEOMYCIN SULFATE (BLEOMYCIN SULFATE). | Antineoplastic Antibiotic | caution |
BLINCYTO Comprehensive clinical and safety monograph for BLINCYTO (BLINCYTO). | Antineoplastic Monoclonal Antibody | caution |
BRUKINSA Comprehensive clinical and safety monograph for BRUKINSA (BRUKINSA). | Antineoplastic BTK Inhibitor | caution |
CABAZITAXEL Comprehensive clinical and safety monograph for CABAZITAXEL (CABAZITAXEL). | Taxane Antineoplastic | caution |
CAMPATH Comprehensive clinical and safety monograph for CAMPATH (CAMPATH). | Monoclonal Antibody, Antineoplastic | caution |
CAMPTOSAR Comprehensive clinical and safety monograph for CAMPTOSAR (CAMPTOSAR). | Topoisomerase I Inhibitor Antineoplastic | caution |
CARAC Comprehensive clinical and safety monograph for CARAC (CARAC). | Topical Antineoplastic | caution |
CARFILZOMIB Comprehensive clinical and safety monograph for CARFILZOMIB (CARFILZOMIB). | Proteasome Inhibitor Antineoplastic | caution |
CARMUSTINE Comprehensive clinical and safety monograph for CARMUSTINE (CARMUSTINE). | Alkylating Agent Antineoplastic | caution |
CERUBIDINE Comprehensive clinical and safety monograph for CERUBIDINE (CERUBIDINE). | Anthracycline antineoplastic | caution |
CLADRIBINE Comprehensive clinical and safety monograph for CLADRIBINE (CLADRIBINE). | Antineoplastic Agent | caution |
CLOFARABINE Comprehensive clinical and safety monograph for CLOFARABINE (CLOFARABINE). | Antineoplastic Agent | caution |
CLOLAR Comprehensive clinical and safety monograph for CLOLAR (CLOLAR). | Antineoplastic Agent | caution |
COLUMVI Comprehensive clinical and safety monograph for COLUMVI (COLUMVI). | Antineoplastic Agent (Monoclonal Antibody) | caution |
COMETRIQ Comprehensive clinical and safety monograph for COMETRIQ (COMETRIQ). | Antineoplastic (Multikinase Inhibitor) | caution |
COPIKTRA Comprehensive clinical and safety monograph for COPIKTRA (COPIKTRA). | PI3K Inhibitor Antineoplastic | caution |
COSMEGEN Comprehensive clinical and safety monograph for COSMEGEN (COSMEGEN). | Antineoplastic antibiotic | caution |
CYRAMZA Comprehensive clinical and safety monograph for CYRAMZA (CYRAMZA). | Antineoplastic Monoclonal Antibody | caution |
CYTARABINE Comprehensive clinical and safety monograph for CYTARABINE (CYTARABINE). | Antineoplastic Antimetabolite | caution |
CYTOSAR-U Comprehensive clinical and safety monograph for CYTOSAR-U (CYTOSAR-U). | Antineoplastic Antimetabolite | caution |
DANYELZA Comprehensive clinical and safety monograph for DANYELZA (DANYELZA). | Monoclonal Antibody Antineoplastic | caution |
DAUNOXOME Comprehensive clinical and safety monograph for DAUNOXOME (DAUNOXOME). | Anthracycline Antineoplastic | caution |
DECITABINE Comprehensive clinical and safety monograph for DECITABINE (DECITABINE). | Antineoplastic Agent (DNA Demethylating Agent) | caution |
DEPOCYT Comprehensive clinical and safety monograph for DEPOCYT (DEPOCYT). | Antineoplastic | caution |
DOXIL (LIPOSOMAL) Comprehensive clinical and safety monograph for DOXIL (LIPOSOMAL) (DOXIL (LIPOSOMAL)). | Anthracycline Antineoplastic | caution |
DROXIA Comprehensive clinical and safety monograph for DROXIA (DROXIA). | Antineoplastic | caution |
DTIC-DOME Comprehensive clinical and safety monograph for DTIC-DOME (DTIC-DOME). | Antineoplastic | caution |
EFUDEX Comprehensive clinical and safety monograph for EFUDEX (EFUDEX). | Topical Antineoplastic | caution |
EKTERLY Comprehensive clinical and safety monograph for EKTERLY (EKTERLY). | Antineoplastic Agent | caution |
ELAHERE Comprehensive clinical and safety monograph for ELAHERE (ELAHERE). | Antineoplastic Agent | caution |
ELIGARD KIT Comprehensive clinical and safety monograph for ELIGARD KIT (ELIGARD KIT). | GnRH Agonist Antineoplastic | caution |
ELLENCE Comprehensive clinical and safety monograph for ELLENCE (ELLENCE). | Anthracycline Antineoplastic | caution |
ELOXATIN Comprehensive clinical and safety monograph for ELOXATIN (ELOXATIN). | Platinum-Based Antineoplastic | caution |
ELREXFIO Comprehensive clinical and safety monograph for ELREXFIO (ELREXFIO). | Bispecific Antibody Antineoplastic | caution |
ELSPAR Comprehensive clinical and safety monograph for ELSPAR (ELSPAR). | Enzyme Antineoplastic | caution |
EMPLICITI Comprehensive clinical and safety monograph for EMPLICITI (EMPLICITI). | Monoclonal Antibody Antineoplastic | caution |
ENHERTU Comprehensive clinical and safety monograph for ENHERTU (ENHERTU). | Antineoplastic Agent | caution |
EPIOXA HD/EPIOXA KIT Comprehensive clinical and safety monograph for EPIOXA HD/EPIOXA KIT (EPIOXA HD/EPIOXA KIT). | Platinum-Based Antineoplastic | caution |
ERBITUX Comprehensive clinical and safety monograph for ERBITUX (ERBITUX). | EGFR Inhibitor Antineoplastic | caution |
ERIBULIN MESYLATE Comprehensive clinical and safety monograph for ERIBULIN MESYLATE (ERIBULIN MESYLATE). | Microtubule Inhibitor Antineoplastic | caution |
ERIVEDGE Comprehensive clinical and safety monograph for ERIVEDGE (ERIVEDGE). | Hedgehog Pathway Inhibitor Antineoplastic | caution |
ERLEADA Comprehensive clinical and safety monograph for ERLEADA (ERLEADA). | Androgen Receptor Inhibitor Antineoplastic | caution |
ERLOTINIB HYDROCHLORIDE Comprehensive clinical and safety monograph for ERLOTINIB HYDROCHLORIDE (ERLOTINIB HYDROCHLORIDE). | EGFR Inhibitor Antineoplastic | caution |
FLOXURIDINE Comprehensive clinical and safety monograph for FLOXURIDINE (FLOXURIDINE). | Antineoplastic Antimetabolite | caution |
FLUDARA Comprehensive clinical and safety monograph for FLUDARA (FLUDARA). | Antineoplastic Agent | caution |
FLUOROPLEX Comprehensive clinical and safety monograph for FLUOROPLEX (FLUOROPLEX). | Topical Antineoplastic Agent | caution |
FOLEX Comprehensive clinical and safety monograph for FOLEX (FOLEX). | Antineoplastic Agent | caution |
FOLEX PFS Comprehensive clinical and safety monograph for FOLEX PFS (FOLEX PFS). | Antineoplastic Agent | caution |
FOLOTYN Comprehensive clinical and safety monograph for FOLOTYN (FOLOTYN). | Antineoplastic Agent | caution |
FOTIVDA Comprehensive clinical and safety monograph for FOTIVDA (FOTIVDA). | VEGFR inhibitor (Antineoplastic) | caution |
FRUZAQLA Comprehensive clinical and safety monograph for FRUZAQLA (FRUZAQLA). | VEGFR inhibitor (Antineoplastic) | caution |
FUDR Comprehensive clinical and safety monograph for FUDR (FUDR). | Antimetabolite (Antineoplastic) | caution |
HALAVEN Comprehensive clinical and safety monograph for HALAVEN (HALAVEN). | Antineoplastic Agent | caution |
HYDREA Comprehensive clinical and safety monograph for HYDREA (HYDREA). | Antineoplastic | caution |
IDAMYCIN Comprehensive clinical and safety monograph for IDAMYCIN (IDAMYCIN). | Anthracycline Antineoplastic | caution |
IDAMYCIN PFS Comprehensive clinical and safety monograph for IDAMYCIN PFS (IDAMYCIN PFS). | Anthracycline Antineoplastic | caution |
IDVYNSO Comprehensive clinical and safety monograph for IDVYNSO (IDVYNSO). | Antineoplastic Agent | caution |
IMKELDI Comprehensive clinical and safety monograph for IMKELDI (IMKELDI). | Antineoplastic Agent | caution |
INFUGEM Comprehensive clinical and safety monograph for INFUGEM (INFUGEM). | Antimetabolite Antineoplastic Agent | caution |
INGENOL MEBUTATE Comprehensive clinical and safety monograph for INGENOL MEBUTATE (INGENOL MEBUTATE). | Topical Antineoplastic | caution |
IXEMPRA KIT Comprehensive clinical and safety monograph for IXEMPRA KIT (IXEMPRA KIT). | Antineoplastic Microtubule Inhibitor | caution |
JAVADIN Comprehensive clinical and safety monograph for JAVADIN (JAVADIN). | Antineoplastic Agent | caution |
JELMYTO Comprehensive clinical and safety monograph for JELMYTO (JELMYTO). | Antineoplastic Antibiotic | caution |
JEVTANA KIT Comprehensive clinical and safety monograph for JEVTANA KIT (JEVTANA KIT). | Taxane Antineoplastic | caution |
JYLAMVO Comprehensive clinical and safety monograph for JYLAMVO (JYLAMVO). | Antineoplastic Agent | caution |
KADCYLA Comprehensive clinical and safety monograph for KADCYLA (KADCYLA). | Antineoplastic Agent | caution |
KANJINTI Comprehensive clinical and safety monograph for KANJINTI (KANJINTI). | Monoclonal Antibody Antineoplastic | caution |
KIMMTRAK Comprehensive clinical and safety monograph for KIMMTRAK (KIMMTRAK). | Bispecific T-cell Engager Antineoplastic | caution |
KISQALI Comprehensive clinical and safety monograph for KISQALI (KISQALI). | CDK4/6 Inhibitor Antineoplastic | caution |
KISQALI FEMARA CO-PACK (COPACKAGED) Comprehensive clinical and safety monograph for KISQALI FEMARA CO-PACK (COPACKAGED) (KISQALI FEMARA CO-PACK (COPACKAGED)). | CDK4/6 Inhibitor and Aromatase Inhibitor Combination Antineoplastic | caution |
KLISYRI Comprehensive clinical and safety monograph for KLISYRI (KLISYRI). | Topical Antineoplastic for Actinic Keratosis | caution |
LARTRUVO Comprehensive clinical and safety monograph for LARTRUVO (LARTRUVO). | Antineoplastic Agent | caution |
LEUKERAN Comprehensive clinical and safety monograph for LEUKERAN (LEUKERAN). | Antineoplastic (Alkylating Agent) | caution |
LEUSTATIN Comprehensive clinical and safety monograph for LEUSTATIN (LEUSTATIN). | Antineoplastic (Purine Antagonist) | caution |
LONSURF Comprehensive clinical and safety monograph for LONSURF (LONSURF). | Antineoplastic | caution |
LYNAVOY Comprehensive clinical and safety monograph for LYNAVOY (LYNAVOY). | Antineoplastic Agent | caution |
LYSODREN Comprehensive clinical and safety monograph for LYSODREN (LYSODREN). | Antineoplastic | caution |
MARGENZA Comprehensive clinical and safety monograph for MARGENZA (MARGENZA). | Antineoplastic Agent | caution |
MARQIBO KIT Comprehensive clinical and safety monograph for MARQIBO KIT (MARQIBO KIT). | Antineoplastic Agent | caution |
MATULANE Comprehensive clinical and safety monograph for MATULANE (MATULANE). | Antineoplastic Agent | caution |
MAVENCLAD Comprehensive clinical and safety monograph for MAVENCLAD (MAVENCLAD). | Antineoplastic Agent | caution |
MEXATE Comprehensive clinical and safety monograph for MEXATE (MEXATE). | Antineoplastic Agent | caution |
MEXATE-AQ Comprehensive clinical and safety monograph for MEXATE-AQ (MEXATE-AQ). | Antineoplastic Agent | caution |
MEXATE-AQ PRESERVED Comprehensive clinical and safety monograph for MEXATE-AQ PRESERVED (MEXATE-AQ PRESERVED). | Antineoplastic Agent | caution |
MITHRACIN Comprehensive clinical and safety monograph for MITHRACIN (MITHRACIN). | Antineoplastic Antibiotic | caution |
MITOSOL Comprehensive clinical and safety monograph for MITOSOL (MITOSOL). | Antineoplastic Antibiotic | caution |
MITOZYTREX Comprehensive clinical and safety monograph for MITOZYTREX (MITOZYTREX). | Antineoplastic (Anthracenedione) | caution |
MONJUVI Comprehensive clinical and safety monograph for MONJUVI (MONJUVI). | Antineoplastic | caution |
MYLERAN Comprehensive clinical and safety monograph for MYLERAN (MYLERAN). | Alkylating Antineoplastic | caution |
NAVELBINE Comprehensive clinical and safety monograph for NAVELBINE (NAVELBINE). | Vinca Alkaloid Antineoplastic | caution |
NAVSTEL Comprehensive clinical and safety monograph for NAVSTEL (NAVSTEL). | Vinca Alkaloid Antineoplastic | caution |
NELARABINE Comprehensive clinical and safety monograph for NELARABINE (NELARABINE). | Antineoplastic Agent | caution |
NEMLUVIO Comprehensive clinical and safety monograph for NEMLUVIO (NEMLUVIO). | Antineoplastic Agent | caution |
NIKTIMVO Comprehensive clinical and safety monograph for NIKTIMVO (NIKTIMVO). | Antineoplastic agent | caution |
NIPENT Comprehensive clinical and safety monograph for NIPENT (NIPENT). | Antineoplastic Agent | caution |
NOVANTRONE Comprehensive clinical and safety monograph for NOVANTRONE (NOVANTRONE). | Antineoplastic Agent | caution |
OFORTA Comprehensive clinical and safety monograph for OFORTA (OFORTA). | Antineoplastic (Asparaginase) | caution |
OGSIVEO Comprehensive clinical and safety monograph for OGSIVEO (OGSIVEO). | Antineoplastic (Multi-kinase Inhibitor) | caution |
ONCASPAR Comprehensive clinical and safety monograph for ONCASPAR (ONCASPAR). | Antineoplastic Enzyme (Asparaginase) | caution |
ONUREG Comprehensive clinical and safety monograph for ONUREG (ONUREG). | Antineoplastic Agent (Hypomethylating Agent) | caution |
OPDIVO Comprehensive clinical and safety monograph for OPDIVO (OPDIVO). | Antineoplastic Agent (PD-1 Inhibitor) | caution |
OPDIVO QVANTIG Comprehensive clinical and safety monograph for OPDIVO QVANTIG (OPDIVO QVANTIG). | Antineoplastic Agent (PD-1 Inhibitor Combination) | caution |
OPDUALAG Comprehensive clinical and safety monograph for OPDUALAG (OPDUALAG). | Antineoplastic Agent (Immune Checkpoint Inhibitor Combination) | caution |
OSIMERTINIB MESYLATE Comprehensive clinical and safety monograph for OSIMERTINIB MESYLATE (OSIMERTINIB MESYLATE). | Antineoplastic Agent | caution |
PADCEV Comprehensive clinical and safety monograph for PADCEV (PADCEV). | Antineoplastic Agent | caution |
PARAPLATIN Comprehensive clinical and safety monograph for PARAPLATIN (PARAPLATIN). | Antineoplastic Agent | caution |
PEMETREXED Comprehensive clinical and safety monograph for PEMETREXED (PEMETREXED). | Antineoplastic Antifolate | caution |
PEMETREXED DISODIUM Comprehensive clinical and safety monograph for PEMETREXED DISODIUM (PEMETREXED DISODIUM). | Antineoplastic Antifolate | caution |
PEMETREXED DITROMETHAMINE Comprehensive clinical and safety monograph for PEMETREXED DITROMETHAMINE (PEMETREXED DITROMETHAMINE). | Antineoplastic Antifolate | caution |
PEMETREXED FOR INJECTION Comprehensive clinical and safety monograph for PEMETREXED FOR INJECTION (PEMETREXED FOR INJECTION). | Antineoplastic Antifolate | caution |
PEMFEXY Comprehensive clinical and safety monograph for PEMFEXY (PEMFEXY). | Antineoplastic Antifolate | caution |
PENPULIMAB-KCQX Comprehensive clinical and safety monograph for PENPULIMAB-KCQX (PENPULIMAB-KCQX). | Antineoplastic Monoclonal Antibody | caution |
PENTOSTATIN Comprehensive clinical and safety monograph for PENTOSTATIN (PENTOSTATIN). | Antineoplastic Adenosine Deaminase Inhibitor | caution |
PHOSPHOCOL P32 Comprehensive clinical and safety monograph for PHOSPHOCOL P32 (PHOSPHOCOL P32). | Radiopharmaceutical (Antineoplastic) | caution |
PHOTOFRIN Comprehensive clinical and safety monograph for PHOTOFRIN (PHOTOFRIN). | Photosensitizer (Antineoplastic) | caution |
PICATO Comprehensive clinical and safety monograph for PICATO (PICATO). | Topical Antineoplastic | caution |
POLIVY Comprehensive clinical and safety monograph for POLIVY (POLIVY). | Antineoplastic Agent | caution |
PORTRAZZA Comprehensive clinical and safety monograph for PORTRAZZA (PORTRAZZA). | Antineoplastic Monoclonal Antibody | caution |
POTELIGEO Comprehensive clinical and safety monograph for POTELIGEO (POTELIGEO). | Monoclonal Antibody Antineoplastic | caution |
PRALATREXATE Comprehensive clinical and safety monograph for PRALATREXATE (PRALATREXATE). | Antineoplastic | caution |
PURINETHOL Comprehensive clinical and safety monograph for PURINETHOL (PURINETHOL). | Antineoplastic Agent | caution |
REDITREX Comprehensive clinical and safety monograph for REDITREX (REDITREX). | Antineoplastic Antimetabolite | caution |
RHUZDAH Comprehensive clinical and safety monograph for RHUZDAH (RHUZDAH). | Antineoplastic (Kinase Inhibitor) | caution |
RITUXAN Comprehensive clinical and safety monograph for RITUXAN (RITUXAN). | Antineoplastic Agent | caution |
RYBREVANT Comprehensive clinical and safety monograph for RYBREVANT (RYBREVANT). | Bispecific EGFR-MET Antibody Antineoplastic | caution |
RYBREVANT FASPRO Comprehensive clinical and safety monograph for RYBREVANT FASPRO (RYBREVANT FASPRO). | Bispecific EGFR-MET Antibody Antineoplastic | caution |
RYDAPT Comprehensive clinical and safety monograph for RYDAPT (RYDAPT). | FLT3 Kinase Inhibitor Antineoplastic | caution |
RYLAZE Comprehensive clinical and safety monograph for RYLAZE (RYLAZE). | Antineoplastic Enzyme | caution |
RYTELO Comprehensive clinical and safety monograph for RYTELO (RYTELO). | Telomerase Inhibitor Antineoplastic | caution |
SARCLISA Comprehensive clinical and safety monograph for SARCLISA (SARCLISA). | Monoclonal Antibody, Antineoplastic | caution |
SCEMBLIX Comprehensive clinical and safety monograph for SCEMBLIX (SCEMBLIX). | Tyrosine Kinase Inhibitor, Antineoplastic | caution |
SONORX Comprehensive clinical and safety monograph for SONORX (SONORX). | Antineoplastic agent | caution |
SUTENT Comprehensive clinical and safety monograph for SUTENT (SUTENT). | Tyrosine Kinase Inhibitor Antineoplastic | caution |
SYLATRON Comprehensive clinical and safety monograph for SYLATRON (SYLATRON). | Interferon Antineoplastic/Antiviral | caution |
SYLVANT Comprehensive clinical and safety monograph for SYLVANT (SYLVANT). | Monoclonal Antibody Antineoplastic | caution |
SYNRIBO Comprehensive clinical and safety monograph for SYNRIBO (SYNRIBO). | Antineoplastic | caution |
TAXOL Comprehensive clinical and safety monograph for TAXOL (TAXOL). | Taxane Antineoplastic | caution |
TAXOTERE Comprehensive clinical and safety monograph for TAXOTERE (TAXOTERE). | Taxane Antineoplastic | caution |
TAZVERIK Comprehensive clinical and safety monograph for TAZVERIK (TAZVERIK). | Antineoplastic, EZH2 Inhibitor | caution |
TECENTRIQ Comprehensive clinical and safety monograph for TECENTRIQ (TECENTRIQ). | Antineoplastic, PD-L1 Inhibitor | caution |
TECENTRIQ HYBREZA Comprehensive clinical and safety monograph for TECENTRIQ HYBREZA (TECENTRIQ HYBREZA). | Antineoplastic, PD-L1 Inhibitor | caution |
TECVAYLI Comprehensive clinical and safety monograph for TECVAYLI (TECVAYLI). | Antineoplastic | caution |
TEMBEXA Comprehensive clinical and safety monograph for TEMBEXA (TEMBEXA). | Antineoplastic (retinoid) | caution |
TEMODAR Comprehensive clinical and safety monograph for TEMODAR (TEMODAR). | Antineoplastic (alkylating agent) | caution |
TEPADINA Comprehensive clinical and safety monograph for TEPADINA (TEPADINA). | Antineoplastic (alkylating agent) | caution |
THIOPLEX Comprehensive clinical and safety monograph for THIOPLEX (THIOPLEX). | Alkylating Antineoplastic | caution |
TIBSOVO Comprehensive clinical and safety monograph for TIBSOVO (TIBSOVO). | Antineoplastic Agent | caution |
TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE Comprehensive clinical and safety monograph for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE (TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE). | Antineoplastic Agent | caution |
TIVDAK Comprehensive clinical and safety monograph for TIVDAK (TIVDAK). | Antineoplastic agent (antibody-drug conjugate) | caution |
TOPOSAR Comprehensive clinical and safety monograph for TOPOSAR (TOPOSAR). | Antineoplastic (Etoposide) | caution |
TOPOTECAN Comprehensive clinical and safety monograph for TOPOTECAN (TOPOTECAN). | Antineoplastic (Topoisomerase Inhibitor) | caution |
TOPOTECAN HYDROCHLORIDE Comprehensive clinical and safety monograph for TOPOTECAN HYDROCHLORIDE (TOPOTECAN HYDROCHLORIDE). | Antineoplastic (Topoisomerase Inhibitor) | caution |
TRABECTEDIN Comprehensive clinical and safety monograph for TRABECTEDIN (TRABECTEDIN). | Antineoplastic Agent | caution |
TRISENOX Comprehensive clinical and safety monograph for TRISENOX (TRISENOX). | Antineoplastic, Arsenic Trioxide | caution |
TRODELVY Comprehensive clinical and safety monograph for TRODELVY (TRODELVY). | Trop-2-directed Antibody-Drug Conjugate (Antineoplastic) | caution |
UVADEX Comprehensive clinical and safety monograph for UVADEX (UVADEX). | Antineoplastic Agent | caution |
VALRUBICIN Comprehensive clinical and safety monograph for VALRUBICIN (VALRUBICIN). | Anthracycline Antineoplastic | caution |
VALSTAR PRESERVATIVE FREE Comprehensive clinical and safety monograph for VALSTAR PRESERVATIVE FREE (VALSTAR PRESERVATIVE FREE). | Anthracycline Antineoplastic | caution |
VANFLYTA Comprehensive clinical and safety monograph for VANFLYTA (VANFLYTA). | IDH1 Inhibitor Antineoplastic | caution |
VECTIBIX Comprehensive clinical and safety monograph for VECTIBIX (VECTIBIX). | Antineoplastic Monoclonal Antibody | caution |
VEGZELMA Comprehensive clinical and safety monograph for VEGZELMA (VEGZELMA). | Antineoplastic Monoclonal Antibody | caution |
VELBAN Comprehensive clinical and safety monograph for VELBAN (VELBAN). | Antineoplastic Vinca Alkaloid | caution |
VELCADE Comprehensive clinical and safety monograph for VELCADE (VELCADE). | Antineoplastic Proteasome Inhibitor | caution |
VERCYTE Comprehensive clinical and safety monograph for VERCYTE (VERCYTE). | Antineoplastic Antimetabolite | caution |
VESANOID Comprehensive clinical and safety monograph for VESANOID (VESANOID). | Retinoid Antineoplastic | caution |
VINCASAR PFS Comprehensive clinical and safety monograph for VINCASAR PFS (VINCASAR PFS). | Vinca Alkaloid Antineoplastic | caution |
VINCREX Comprehensive clinical and safety monograph for VINCREX (VINCREX). | Vinca Alkaloid Antineoplastic | caution |
VOYXACT Comprehensive clinical and safety monograph for VOYXACT (VOYXACT). | Antineoplastic | caution |
VYLOY Comprehensive clinical and safety monograph for VYLOY (VYLOY). | Antineoplastic Agent | caution |
VYXEOS Comprehensive clinical and safety monograph for VYXEOS (VYXEOS). | Liposomal Antineoplastic Combination | caution |
XOSPATA Comprehensive clinical and safety monograph for XOSPATA (XOSPATA). | Antineoplastic | caution |
XPOVIO Comprehensive clinical and safety monograph for XPOVIO (XPOVIO). | Antineoplastic | caution |
XTANDI Comprehensive clinical and safety monograph for XTANDI (XTANDI). | Antineoplastic | caution |
YONDELIS Comprehensive clinical and safety monograph for YONDELIS (YONDELIS). | Alkylating Antineoplastic Agent | caution |
ZANOSAR Comprehensive clinical and safety monograph for ZANOSAR (ZANOSAR). | Alkylating Antineoplastic Agent | caution |
ZEVALIN Comprehensive clinical and safety monograph for ZEVALIN (ZEVALIN). | Antineoplastic (Radioconjugate) | caution |
ZIIHERA Comprehensive clinical and safety monograph for ZIIHERA (ZIIHERA). | Antineoplastic (HER2 Inhibitor) | caution |
ZYDELIG Comprehensive clinical and safety monograph for ZYDELIG (ZYDELIG). | PI3K Inhibitor Antineoplastic | caution |
ZYKADIA Comprehensive clinical and safety monograph for ZYKADIA (ZYKADIA). | ALK Inhibitor Antineoplastic | caution |
ZYNLONTA Comprehensive clinical and safety monograph for ZYNLONTA (ZYNLONTA). | Antineoplastic Agent | caution |
ZYTIGA Comprehensive clinical and safety monograph for ZYTIGA (ZYTIGA). | Antineoplastic Agent | caution |